Corbus Pharmaceuticals Holdings, Inc. (CRBP) Wednesday announced that it has appointed Dominic Smethurst as its chief medical officer.
Smethurst has over 20 years of experience in the pharmaceutical and biotechnology sector, including the UK's National Health Service. Most recently he was the CMO of Bicycle Therapeutics.
In pre-market activity, Corbus shares are trading at $26.75, up 2.61% on the Nasdaq.
For comments and feedback contact: editorial@rttnews.com
Business News
May 01, 2026 15:54 ET Central banks dominated the economics news flow this week with almost all major ones announcing their latest policy decisions and many boosted expectations for a rate hike in June. In other news, several countries released the preliminary data for first quarter economic growth. In the U.S., comments by Fed Chair Jerome Powell were also in focus as his term ends this month.